Abstract Recently the concept that gap junctions play a role in cancer cell metastasis has emerged. However, the mechanism by which this might occur is unknown. To examine this issue a metastatic breast cancer cell line, MDA-MB-435, was stably transfected with human Cx43 cDNA. Four clones of 435 transfectants (435/Cx43
Introduction
Considerable evidence suggests that gap junctional intercellular communication (GJIC) and the expression of connexins, the protein sub units of gap junctional channels, are linked to tumorigenesis [1, 2] and progression toward metastasis [3, 4] . Several studies also suggest that GJIC and connexins contribute to suppression of tumor growth by participating in the regulation of cell proliferation, differentiation and death [5] [6] [7] . Our previous data suggest that the highly metastatic breast cancer cell line MDA-MB-435 expresses connexin 32 (Cx32), but not connexin 43 (Cx43), while non tumorigenic non metastatic breast epithelial cells (hTERT-HME1) express Cx43 and connexin (Cx26), but no Cx32 [8] . We also found that MDA-MB-435 cells express phenotypic markers of osteoblastic cells including osteopontin, osteocalcin and Cbfa-1 [9] . Furthermore, we demonstrated that MDA-MB-435 cells expressing the metastasis suppressing gene BRMS1, display reduced expression of Cx32 and osteopontin and slightly restored Cx43 expression [8] . To further address the role of GJIC and connexin expression in tumorigenesis and metastasis, MDA-MB-435 cells were stably transfected with full length human Cx43 cDNA. Using these transfectants, we examined connexin expression, GJIC, cell number, apoptosis, invasion, migration and cadherin protein expression in vitro. In an in vivo study, we injected immunocompromised mice with MDA-MB-435 cells expressing Cx43 or controls and examined growth rates and size of orthotopic tumors as well as number of visible metastases in lungs recovered from injected mice.
Materials and methods

Reagents
All reagents were of analytical grade and commercially available. Monoclonal and polyclonal antibodies against Cx43, (catalog # 13-8300), N-cadherin (catalog # 33-3900), OB-cadherin (catalog # 32-1700) and E-cadherin (catalog # 13-1700) were purchased from Zymed (South San Francisco, USA). The oligonucleotides for the probes and primers for Cx43 were synthesized by Biosearch Technologies, Inc (Novata, USA). cDNA probes for Cx43, Cx26 and Cx32 were prepared as previously described [10, 11] . The human osteoblastic cell line, hFOB 1.19, was provided by Steven Harris [12] . MDA-MB-435, hTERT-HME1 (human non cancer breast epithelial cells immortalized by infection with the retrovirus pBabepuro ?hTERT vectorline) and HUV-EC-C (human umbilical vein endothelial cell line) were purchased from ATCC (Rockville, USA). pcDNA3.1/hygromycin B (-), hygromycin B, ampicillin, Top10 One Shot kits and Lipofectamine reagents were purchased from Invitrogen (Carlsbad, USA), BamHI, XbaI, KpnI and T4 DNA ligase from Boehringer Mannheim (Indianapolis, USA), and Qiaquick Gel Extraction, EndoFree Plasmid and RNeasy kits from Qiagen (Valencia, USA).
Development of Cx43 expressing MDA-MB-435 cells A 1,817 bp fragment of human Cx43 cDNA [13] was ligated into the XbaI and KpnI sites of the pcDNA3.1/hygro (-) vector in the sense orientation. The sense orientation structure of pcDNA3.1/hygro (-)/human Cx43
? was analyzed and confirmed by sequence analysis (sequencer ABI model 377; Forster, CA) and was designated Cx43 ? (c1, c6, c8 and c14) expressing higher levels of Cx43 mRNA, Cx43 protein and GJIC and two clones of plasmid control 435/hy5 (hy5) and 435/hy6 (hy6) were selected for this study. One more control, hy4, was added for in vivo metastasis assay.
Quantification of gap functional intercellular communication (GJIC)
GJIC was assessed by dual label dye transfer and fluorescent activated cell sorting (FACS) as previously described [8, 14, 15] . Briefly, donor cells were double-labeled by a 30-min exposure to the gap junction permeable dye calcein AM (10 lM/ml) and the lipophilic dye DiI (8.75 lg/mlM) (Molecular Probes, Eugene, OR) in HBSS containing 1% BSA and Pluronic F-127 (Molecule Probes). After one washing with PBS, donor cells were released with trypsin and 1 9 10 4 of these double labeled donor cells were dropped on top of a layer of unlabeled acceptor cells and the co-culture incubated for 2 h at 37°C and 5% CO 2 . The co-cultures were then released with trypsin. After fixation with 2% paraformaldehyde for 15 min cells were resuspended in FACS buffer and assessed by FACS analysis.
Invasion and migration assay
A BioCoat FluoroBlok Invasion System (with Matrigel Ò coated multiwell inserts) and FluoroBlok Multiwell insert system (with uncoated multiwell inserts, both form Becton Dickinson Labware, Bedlard, USA) were used to examine cell invasion and migration, respectively. Briefly, Matrigel Ò coated multiwall inserts for invasion assays were rehydrated with 0.5 ml of PBS at 37°C PBS followed by incubation at 37°C in an incubator, without CO 2 , for 2 h. Multiwell inserts for migration assays were not rehydrated. For both invasion and migration assays hTERT-HME1 cells and clones of 435/Cx43
? and 435/hy were cultured until confluent. On the day of the experiment cells were released with trypsin and suspended in culture medium without serum. A suspension of cells at 2.5 9 10 4 cells per 0.5 ml media was added to the top of the invasion or migration inserts and 0.75 ml of culture medium containing 10% FBS was added to the bottom chamber, as a chemo attractant, and the chamber incubated for 22 h. The medium was removed from the upper chamber, and the invading cells or migrating cells on the bottom of the insert well were stained with 1 mM calcein for 1 h in an incubator (37°C, 5% CO 2 ). The extra calcein dye was removed by immersing the insert wells into a fresh 24-well plate containing PBS. Invasion or migration of cells was assessed by reading the fluorescence of invading or migrating cells using a fluorescence plate reader at excitation/emission wave-lengths of 485/530 nm.
Quantitative analysis of protein levels by Western blot
Steady state level of protein was assessed by Western blot analysis. Total cellular protein was assessed using antibodies against Cx43, E-cadherin, N-cadherin, OB-cadherin and, as a control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH; purchased from Accurate Chemical and Scientific Corp. Westbury USA; catalog # YBG6999555) as previously described [13] . Equivalent amounts of each protein (40 lg) were applied to 10% pre-cast SDS-polyacrylamide gels (Bio-Rad, Hercules, USA) at 100 volts for 1.5 h and transferred to nitrocellulose membranes at 40 volts overnight at 4°C. The membranes were blocked by a blocking solution containing 5% non-fat milk, 0.05% Tween-20 Tris-Buffered-Saline (TBS; (Bio-Rad) for 1 h before incubation for 3 h at room temperature with each antibody (diluted 1:1,000 to 1:500 in blocking solution). The membranes were washed three times with 0.05% Tween-20 TBS and incubated for 1 h with goat anti-mouse (for monoclonal antibodies) or goat anti-rabbit (for polyclonal antibodies) IgG linked to horseradish peroxidase (Bio-Rad) diluted 1:3,000 in blocking solution. After three additional washes with 0.05% Tween-20 TBS, membranes were soaked in enhanced chemiluminescence (ECL) detection reagents (Amersham, UK). The membranes were then air-dried and exposed to X-ray film. Densitometry measurements were performed using a Bio-Rad Q-one program (Bio-Rad). Data from optical density readings of protein were normalized to GAPDH.
Quantitative real-time RT-PCR Total RNA was isolated from each cell line using a Qiagen RNeasy mini kit. Gene Expression was quantified by realtime RT-PCR using an Applied Biosystems 7300 RealTime PCR System (Applied Biosystems, Foster City, USA) as previously described [13] . Primers and probes were designed using sequence data from Genbank and the realtime PCR probe/primer design software Primer Express (version 1.0, Applied Biosystems). The sequences of primers and probes are as follow: for Cx43; forward primer 5 0 GCT CCT CAC CAA CCG CT3 0 , reverse primer 5 0 TTG CGG CAG GAG GAA TTG3 0 and probe TCT CAC CTA TGT CTC CTC CTG GGT ACA A3 0 (NM_000166). For Cx32; forward primer CAA CAG CGT TTG CTA TGA CCA C3 0 , reverse primer 5 0 -TGA GCT GCA GGG ACC ACA and probe CTT CCC CAT CTC CCA TGT GCG G (NM_000166). For real time qPCR analysis, DNAse-treated RNA was reverse-transcribed using High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA) and the protocol provided with the kit. Quantification by real-time PCR was accomplished by adding 10 or 20 ng of cDNA in a reaction with 29 TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, USA) in a volume of 20 ll. Primer was added at a concentration of 400 nM and a probe which was labeled with a 5 0 FAM and a 3 0 Black Hole Quencher (Biosearch Tech, Novato, CA) was added at 200 nM. The amplification protocol consisted of 2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. Ct values of genes of interest and the reference gene 18S were calculated using the delta Ct method to determine relative steady state mRNA levels.
Cell number and caspase-3-activity 0.5 9 10 5 cells were seeded into 10 mm dishes and cultured for 3 days. Cell numbers were quantified at 3 days using a hemocytometer. Caspase-3 activity was quantified using a Caspase-3 Fluorescent Assay kit (Clonetech Laboratories, Inc, Palo Alto, USA) according to the manufactures instructions. Briefly, cells were cultured in 0.2% FCS culture medium with 1 lM retinoic acid (RA) for 9 days before the assay. On the day of assay, 1 9 10 6 cells were suspended in chilled cell lyses buffer supplied in the kit and incubated for 10 min on ice. Cell lysates were centrifuged in a micro centrifuge at maximum speed for 3 min at 4°C to precipitate cell debris and the supernatants transferred to a new tube. 50 ll of 29 Reaction buffer/DTT mix and 1 ll of DEVD-Cho inhibitor were added to 50 ll of the supernatant which was then mixed and incubated at 37°C for 30 min in a shaking water bath. Other samples were kept on ice. After 30 min of shaking, 50 ll of 29 Reaction buffer/DTT mix was added to each reaction. Then, 5 ll of 1 mM caspase-substrate was added to each sample, including control, and the samples were placed in a 37°C water bath for 1 h. A calibration curve was generated using standards provided by the manufacture. Finally, all samples were transferred to a 96-well plate and read by a fluorometer (Bio-Rad, Hercules, USA) with 400 nm excitation and 505 nm emission filters.
In vivo tumorigenesis and metastasis Spontaneous metastases was quantified as previously described [16] . Briefly, 56 athymic nu/nu-Foxn1(nu) mice (Harlan, Indianapolis, USA) were randomly placed into two groups: 32 mice for 435/Cx43
? (c1, c6, c8 and c14) and 24 mice for plasmid control 435/hy (hy4, hy5, hy6) and cells from each clonal line were injected into eight mice. 1 9 10 6 cells of each clone were injected into exposed axillary mammary fat pads of anesthetized 5-to 6-weekold female mice. To estimate tumorigenicity, orthotopic tumor size (OTS) was quantified starting 1 week after injection. The growth rate was monitored by diameter measurement of orthotopic tumor. When the mean tumor diameter reached 1.2-1.5 cm, tumors were surgically removed under ketamin:xylazine (80-85 mg/kg:14-16 mg/ kg) anesthesia and the wounds were closed with sterile stainless steel clips. Two months later, mice were killed and examined for the presence of metastases. Lungs were removed, rinsed in water, and fixed in Bouin's solution before quantification of surface metastases as described previously [16, 17] . We did not section lungs or examine lungs histologically as we have verified previously that metastases on lung surfaces account for greater than 80% of metastases due to the lungs anatomy [17] .
Statistical analysis
All experiments were performed in duplicate, and in some cases triplicate, at least four times. Data are from four clones of Cx43 transfectants, two clones of plasmid control, accept in the case of in vivo experiments where three clones of plasmid controls were injected, and hTERT-HME1 cells. All date are reported as the mean ± SEM. Statistical significance was assessed by one-way analysis of variance (ANOVA) followed by a student-Newman-Keuls test and P \ 0.05 was considered significant.
Results
Quantitative analysis of steady state protein and mRNA levels by Western blot and real time RT-PCR, respectively, revealed that Cx43 protein and Cx43 mRNA were expressed in all clones of 435/Cx43
? including c1, c6, c8
and c14 as well as in human breast epithelial cells hTERT-HME1. However, Cx43 was not detected in 435/hy and (Fig. 1a) . Cx43 protein and mRNA in 435/Cx43 ? were significantly increased relative to 435/hy (Fig. 1b, c) . Cx43 mRNA in hTERT-HME1 was greater than in 435/hy cells but lower than in 435/Cx43
? (Fig. 1c) . Steady state Cx32 mRNA levels were significantly decreased in 435/Cx43 ? relative to 435/hy cells while Cx32 was not detected in hTERT-HME1 (Fig. 1d) . GJIC in hTERT-HME1 was greater than in any of the other cell lines examined while it was similar in 435/Cx43
? and 435/hy (Fig. 1e ). Invasion and migration were similar in all cell lines examined (Fig. 2a, b) . However, the number of 435/ Cx43
? , as assessed by cell counts, was significantly decreased relative to that in 435/hy. The number of hTERT-HME1 and 435/Cx43
? was similar (Fig. 2c ). Caspase-3 activity in 435/Cx43
? was significantly increased relative to that in 435/hy (Fig. 2d) .
Western blot analysis revealed that all clones of 435/ Cx43
? , 435/hy and hTERT-HME1 cells expressed OBcadherin ( Fig. 3a) and N-cadherin (Fig. 3b) proteins albeit at different abundances. Levels of OB-cadherin protein in 435/Cx43
? and 435/hy were not statistically different from one another, but both were significantly decreased relative to hTERT-HME1 cells (Fig. 3c) . Levels of N-cadherin protein in 435/Cx43
? were significantly decreased relative to those in 435/hy. hTERT-HME1 cells expressed a very small amount of N-cadherin protein (Fig. 3d ). E-cadherin protein was detected only in hTERT-HME1 (data not shown).
In vivo data revealed that OTS on day 7 post-injection was similar in mice injected with either 435/Cx43
? or 435/ hy. However, at 30 days post injection mice injected with 435/Cx43
? cells had slightly, but statistically significant, larger tumors than mice injected with 435/hy while 60 days post-injection, mice injected with 435/Cx43
? had slightly, but statistically significant, smaller tumors than mice injected with 435/hy (Fig. 4a) . More importantly, the number of metastases recovered in lungs of nude mice injected with 435/Cx43
? was significantly decreased (nearly 50%) relative to mice injected with 435/hy (Fig. 4b) .
Discussion
In support of previous studies reported in the literature [18] , including our own [8] , we found that Cx43 levels were reduced in breast cancer cells relative to non cancerous breast epithelial cells. On the other hand, Cx32 levels were up regulated in breast cancer cell lines, relative to non cancerous breast epithelial cells, and expressing Cx43 in breast cancer cell lines resulted in a decrease in Cx32 expression. These findings suggest that the connexin expression profile changes as breast epithelial cells transition to cancerous cells and that there is an inverse relationship between Cx43 and Cx32 expression in breast epithelial cells and breast cancer cells.
Recent studies form our laboratory suggest that expressing Cx43 in breast cancer cells decreases their invasion through Matrigel Ò and adhesion to endothelial cells [15] suggesting that expressing Cx43 would alter the metastatic potential of breast cancer cells. To address this we injected our Cx43 expressing breast cancer cells into immunocompromised mice. Sixty days after injection the tumor size in mice injected with Cx43 expressing cells was significantly reduced relative to tumor size in mice injected with vector controls. These results are consistent with those reported by Hirsch et al. [19] showing that expressing Cx43 in MDA-MB-435 cells results in growth suppression and similar, although less dramatic, to results reported by Qin et al. [20] demonstrating that over expression of Cx43 in another breast cancer cell line, MDA-MB-231, results in decreased tumor growth in mice. Additionally, we also found that the number of metastases to lungs was reduced in mice injected with Cx43 expressing breast cancer cells relative to mice injected with vector controls. It is possible that the decreased metastasis observed in mice injected with 435/Cx43
? cells, relative to mice injected with 435/hy cells, was at least partly due to the decreased size of the tumor in these mice at 60 days. However, it is unlikely that the decreased tumor size in mice injected with 435/Cx43
? was, by itself, responsible for the decreased metastasis. While mice injected with 435/Cx43
? had tumors 13% smaller than in those injected with 435/hy, the number of metastases was reduced nearly 55%. This suggest that at least some of the decreased metastasis in mice injected with 435/Cx43
? was independent of the decreased tumor size in these mice. Taken together these results support the concept that decreased Cx43 expression contributes to tumorigenesis and offer the first direct in vivo evidence that decreased Cx43 plays a role in metastasis.
To examine the mechanism by which decreased Cx43 expression contributes to breast cancer cell metastasis we first examined homotypic GJIC within each cell line examined. Interestingly, GJIC was reduced in 435/hy breast cancer cells, but increasing Cx43 expression in these cells did not restore GJIC. This is consistent with previous findings from our laboratory as well as others [15, 20] . While Cx43 levels in stably transfected 435/Cx43
? clones were lower than in hTERT, they were increased relative to levels in 435/hy. The decreased expression in 435/hy cells, a breast cancer cell line, relative to hTERT, a model for ''normal'' breast epithelial, is consistent with previous reports of decreased Cx43 levels in breast cancer cells as they become tumorigenic [21] . Expressing Cx43 in 435 cells increases their Cx43 expression and but did not restore GJIC. This suggests that in addition to a decreased expression of Cx43 protein in 435/hy cells relative to hTERT cells there is a post translational defect (e.g. impaired trafficking of connexins to the membrane and formation of connexons, impaired docking with adjacent connexons, or impaired channel gating) in 435/hy cells, that is not alleviated by expressing Cx43 in 435/Cx43
? cells, that precludes full restoration of GJIC. In any case, these results suggest that the anti tumorigenic and anti metastatic effect of Cx43 expression is independent of GJIC.
We previously demonstrated that restoring Cx43 expression in another breast cancer cell line, MDA-MB-231, decreased invasion through Matrigel Ò and adhesion to human umbilical vein endothelial cells but did not affect migration. In this study, we found a similar trend towards a decrease in Matrigel Ò invasion in Cx43 expressing MDA-MB-435 cells but this did not reach statistical significance nor did the change in cell migration. Therefore, it is unlikely that changes in processes involved in Matrigel Ò invasion contribute to the decreased metastasis in Cx43 expressing MDA-MB-435 cells.
We next examined cadherin expression in breast cancer cell lines. Several studies have demonstrated that E-cadherin expression is decreased in invasive breast carcinomas and is directly related to connexin expression [22] [23] [24] . We detected E-cadherin in non cancerous breast epithelial cells but did not detect it in breast cancer cell lines even when Cx43 was over expressed. We recently demonstrated that Cx43 expression in MDA-MB-231 results in decreased expression of OB-cadherin [15] and found a similar trend in Cx43 expressing MDA-MB-435 cells but this did not reach statistical significance. However, we did detect a significant decrease in N-cadherin in Cx43 expressing MDA-MB-231 cells. N-cadherin is involved in increased motility, invasion and metastases of breast cancer cells [25, 26] and thus the decreased expression of N-cadherin in Cx43 over expressing MDA-MB-435 cells may contribute to decreased metastasis in vivo.
Emerging evidence suggests that Cx43 plays a role in apoptosis, but what that role is may be different in different cell systems. For instance, Huang et al. demonstrated that Cx43 enhances apoptosis in response to chemotherapeutic agents [27] or low serum conditions [28] in human glioblastoma cells. On the other hand Cx43 is necessary for the anti apoptotic effect of bisphosphonates [29] and camptothecin induced apoptosis is greater in Cx43 deficient osteoblastic cells [30] . There are no direct studies of the role of Cx43 in breast cancer cell apoptosis. However, it has been demonstrated that Cx43 expression is directly correlated with the expression of BAK (Bcl-2 homologous antagonist/killer), a pro-apoptotic gene of the Bcl-2 family, in human breast cancer tissue [31] . To more directly address this issue we examined retinoic acid induced caspase activity in breast cancer cells expressing Cx43. We found that breast cancer cells expressing Cx43 were more sensitive to the apoptosis inducing effect of retinoic acid than breast cancer cells with less expression of Cx43. These results should be interpreted with caution as retinoic acid also increases GJIC in several cell lines including human mammary-carcinoma MCF-7 [32] However, Saez et al. [32] also reported that the effect of retinoic acid on GJIC was unrelated to its effect on apoptosis. Interestingly, an inverse relationship between N-cadherin expression and apoptosis has also been reported in several cancer cell lines [33, 34] Thus the anti metastatic effect of Cx43 may be related to decreased expression of N-cadherin and enhanced sensitivity to apoptosis.
It is important to note that the origin of MDA-MB-435 cells has recently been called into question with some data suggesting that MDA-MB-435 cells are actually melanocytes [35, 36] . However, MDA-MB-435 cells have been demonstrated to express milk proteins and metastasize from mammary fat pad but not subcutaneous tissue consistent with the cell line being a breast carcinoma [17, 37] . Even if MDA-MB-435 cells are not authentic breast cancer cells it would not alter our interpretation of the data suggesting that Cx43 contributes to cancer cell metastasis.
In summary, our data suggest that expressing Cx43 in breast cancer cells, which normally express very little if any Cx43, decreased their metastatic potential to lung. Interestingly, this appeared to be independent of changes in invasion, migration or GJIC. Rather, it is more likely related to a decrease in N-cadherin expression resulting in an increased sensitivity to apoptosis.
